fluorodeoxyglucose f18 has been researched along with simvastatin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baba, K; Hayabuchi, N; Imaizumi, T; Ishibashi, M; Kai, H; Kaida, H; Nakaura, H; Tahara, N | 1 |
| Fayad, ZA; Machac, J; Rudd, JH | 1 |
| Bonab, AA; Carter, EA; Fischman, AJ; Kaneki, M; Paul, K; Tompkins, RG; Yu, YM | 1 |
1 trial(s) available for fluorodeoxyglucose f18 and simvastatin
| Article | Year |
|---|---|
Simvastatin attenuates plaque inflammation: evaluation by fluorodeoxyglucose positron emission tomography.
Topics: Aged; Aorta, Thoracic; Atherosclerosis; Carotid Stenosis; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Inflammation; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Simvastatin | 2006 |
2 other study(ies) available for fluorodeoxyglucose f18 and simvastatin
| Article | Year |
|---|---|
Simvastatin and plaque inflammation.
Topics: Atherosclerosis; Fluorodeoxyglucose F18; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Positron-Emission Tomography; Radiopharmaceuticals; Simvastatin | 2007 |
Effect of simvastatin on burn-induced alterations in tissue specific glucose metabolism: implications for burn associated insulin resistance.
Topics: Adipose Tissue; Animals; Anticholesteremic Agents; Brain; Burns; Fluorodeoxyglucose F18; Glucose; Glucose Tolerance Test; Humans; Insulin Resistance; Male; Mice; Myocardium; Radiopharmaceuticals; Rats; Simvastatin; Tissue Distribution | 2010 |